Skip to main content

Amundi

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1330387 Paris, I0

Position in PTGX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$942,885
+$509,375 QoQ
Shares Held
7,692
+87.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#181
of 341 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names. PTGX ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $942,885 7,692
2026-03-31 $433,510 4,113
2025-03-31 $99,524 2,058
2024-12-31 $78,473 2,033
2024-09-30 $91,485 2,033
2024-06-30 $93,797 2,707
2024-03-31 $78,313 2,707
2023-12-31 $46,593 2,032
2023-09-30 $62,032 3,719
2023-06-30 $102,718 3,719
2022-03-31 $91,286 3,855
2021-12-31 $138,612 4,053